Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3212]

Highlights from day three, afternoon session, of the 2013 NCRI Cancer Conference

Highlights from day three, afternoon session, of the 2013 NCRI Cancer Conference

FDA approves obinutuzumab for chronic lymphocytic leukaemia

FDA approves obinutuzumab for chronic lymphocytic leukaemia

FDA pulls ponatinib approval due to blood clots and narrowing of blood vessels

FDA pulls ponatinib approval due to blood clots and narrowing of blood vessels

New marketing authorisation application submitted to EMA for ibrutinib for the treatment of two forms of blood cancer

New marketing authorisation application submitted to EMA for ibrutinib for the treatment of two forms of blood...

Launch of the Lymphoma Hub, an online lymphoma community

Launch of the Lymphoma Hub, an online lymphoma community

Gene discovery points to immune link between cancer and multiple sclerosis

Gene discovery points to immune link between cancer and multiple sclerosis

Scientists identify molecular switch that suppresses development of liver cancer

Scientists identify molecular switch that suppresses development of liver cancer

DNA scanning technology leads to new library of cancer targets

DNA scanning technology leads to new library of cancer targets

Research shows genetic anti-inflammatory defect predisposes children to lymphoma

Research shows genetic anti-inflammatory defect predisposes children to lymphoma

ECC 2013: New research shows how aspirin may act on blood platelets to improve survival in colon cancer patients

ECC 2013: New research shows how aspirin may act on blood platelets to improve survival in colon cancer patients

More from ecancer